Biodexa Pharmaceuticals

NASDAQ: BDRX · Real-Time Price · USD
7.08
0.04 (0.57%)
At close: Aug 15, 2025, 3:59 PM
7.00
-1.13%
After-hours: Aug 15, 2025, 07:51 PM EDT

Biodexa Pharmaceuticals Cash Flow Statement

Financials in GBP. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Net Income
-2.42M -3.31M -3.51M -3.57M -4.59M -3.06M -2.31M -3.15M
Depreciation & Amortization
118K 136K 140K 143K 161K 182K 224K 179K
Stock-Based Compensation
133K 150K 13K 15K 23K 100K 52K 37K
Other Working Capital
2.24M n/a n/a -207K 165K -8K n/a n/a
Other Non-Cash Items
-2.6M -487K 151K -367K 506K -528K -1.24M 689K
Deferred Income Tax
-250K n/a n/a -118K -254K 124K -424K 822K
Change in Working Capital
-2.44M -1.3M 262K -104K 396K -232K 372K -859K
Operating Cash Flow
-7.45M -4.81M -2.94M -3.88M -3.51M -3.54M -2.9M -3.11M
Capital Expenditures
-774K n/a -22K -4K -29K -33K -131K -189K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
165K -754K -263K 24K -174K 16K n/a 42K
Investing Cash Flow
156K -754K -285K 20K -203K -17K -131K -147K
Debt Repayment
245K n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-4.64M 4.64M 3.97M 6.25M 125K -78K 8.89M -81K
Financial Cash Flow
3.91M 4.64M 3.97M 6.25M 125K -78K 8.89M -81K
Net Cash Flow
-5.05M 5.05M 372K 1.2M -1.79M 6.42M 2.93M -1.67M
Free Cash Flow
-8.23M -4.81M -2.97M -3.88M -3.54M -3.57M -3.03M -3.3M